Biotech Investment Summit

2018년 10월 31일-11월 2일 • 싱가포르, One Farrer Hotel & Spa

개요

Bioprocess and Technology 및 Biopharma SCMInnovate와 동시에 개최되는 이 서밋에는 아시아 지역을 비롯한 세계 각국의 금융 시장에서 사업을 확대하고 있는 거래사 및 바이오테크놀러지 기업의 인사가 다수 참가할 전망입니다. 컨퍼런스의 주요 목적은 많은 바이오테크놀러지 기업을 소개하고 새로운 시장 기회, 특히 중국 시장에 스포트라이트를 맞추면서 이 기업들과 투자자를 연결하는 것입니다. 또한 투자 평가, 듀 딜리전스(due diligence), M&A 스트럭처링 등을 위한 실용적인 방법에 대해서도 논의합니다.

사업 내용 소개

Biotech Investment Summit에서는 투자자 및 출자를 요구하는 바이오테크놀러지 기업 양측이 강연을 진행합니다. 강연 신청시 간단한 회사 개요를 제공해주시기 바랍니다.

이번 서밋에서 다루어지는 주요 토픽

  • 세계와 아시아 지역의 투자와 출자 동향
  • 메가트렌드와 기술 혁신 - 바이오테크놀러지 분야의 동향과 투자 흐름에 대한 영향
  • 투자자의 심리 - 벤처캐피털, 펀드, 사모펀드, 기관투자가의 견해
  • 투자 기회 분류 - 유망 분야
  • 회사 분할과 M&A의 동향, 향후 전망
  • 신규 주식 공개 전망
  • 신흥 시장에서 사업을 확대하고 있는 기업 소개
  • 중국에 본사를 둔 기업의 평가와 투자
  • 소규모 바이오테크놀러지 기업의 소개와 주식 보유 기회
  • 임상시험에 대한 자금 제공
  • 미개척 시장의 제조시설 건설 프로젝트를 위한 자금조달
  • 투자자에 대한 기업측의 어필
  • 바이오테크놀러지 기업의 듀 딜리전스(Due diligence)
  • 바이오테크놀러지 기업의 규제면 문제와 반트러스트법
  • M&A 스트럭처링

동시 개최 이벤트

4th Annual Bioprocess and Technology 2018 >>
Biopharma SCMInnovate 2018 >>

아젠다

8:00 am

Registration Opens

8:50 am

Chairperson's Opening Remarks

BDP APAC OPENING PLENARY SESSION

GLOBAL INVESTMENT AND FINANCING TRENDS

9:00 am

  • M&A investment trends in life sciences
  • Exponential advances in technology optimising the supply chain
  • New Partnerships and trends-Biopharma focus
  • Key factors impacting future investments

9:30 am

  • Translational research to understand local unmet medical need
  • Addressing ethnic difference through innovative science and development strategies
  • Contributing to collaborative R&D ecosystem to ensure quality

10:00 am

  • AI applications in biopharma market value chain - R&D, clinical trials, business process management and supply chain
  • Using AI tools in pharma - How Asia is progressing?

10:30 am

  • Analysing latest biopharma trends and current unmet needs
  • Effectively forecasting market demand and managing drug supply to patients
  • Lowering the cost-of-goods through cost-effective biomanufacturing strategies
  • Integrating entire biopharma value-chain for better speed to market
  • Supply chain innovation

11:15 am

Morning Break and Networking. End of opening plenary and Biotech Investment Summit Commence

11:45 am

Chairperson's Opening Remarks

BIOTECH INVESTMENT - R&D TO DRUG APPROVAL

  • Analysing Biotech industry in the Asian region
  • Understanding trends in biotechnology
  • The future over the next 5 years

12:10 pm

  • Funding and Investments in value - Total funding capital amount of US$200M since 2001
  • Case study on drug approval - First Class 1.1 China new drug approved by CFDA
  • Impact of alliances: Forming TaiGen and HEC in China, conducted first DDA trial and bring it to market

12:40 pm

  • Case study on startup funding for drug discovery
  • Leveraging experts in biology and drug discovery to create a new way to buildnovel medicines
  • Understanding how technology can be better used for discovery and funding

1:00 pm

Networking Lunch

2:00 pm

  • Investment opportunities and partnerships in the Chronic disease segment
  • Unique and advanced technologies showcase
  • Expanding plan in Asia

2:30 pm

  • Bridging the insurmountable gaps from academia to new drug development
  • Establishing a scientific platform by confirmation of multiple converging new drug targets
  • Incremental success can lead to paradigm shift in CNS drug discovery

3:00 pm

  • Envisions highly efficient automated processes
  • Pharmaceutical technology and return-on-investment
  • Digitalisation projects show case

3:30 pm

Afternoon Break and Networking

BIOTECH AND LENDERS INTERFACE

4:50 pm

  • Obtaining key criteria -project valuation and how lenders use to assess your application
  • Financing and investment models in biotechnology ventures
  • Managing risks - Regulation, listing strategies and market scenarios
  • Where do we see the investment hotspots in Asia?

5:30 pm

End of Conference Day 1

8:50 am

Chairperson's Opening Remarks

MARKET PROFILES - ADVANCED THERAPIES

9:00 am

  • Major Progress update in biotechnology development: Gene & Cell therapy
  • Uncovering the barriers to development ATMP
  • Supporting and financing and risk management

9:30 am

  • Technology and market roadmap
  • Deal Structuring and Investment documentation
  • Capital raising through syndication of world-class investors

10:00 am

  • Indian Novel drug sector overview and market outlook
  • Unique technology trends
  • Smarter clinical development
  • Robust pipeline showcase

10:30 am

Morning Break and Networking

LISTING AND IPO

11:00 am

  • How do venture capitals to evaluate investments?
  • How to have successful IPOs strategy?
  • Listing and IPO criteria and regulatory requirements
  • How to evaluate the risk factors when investing in early-stage start ups

11:30 am

  • The Hong Kong IPO market - new regulations and opportunities
  • Draws GIC to first pre-profit biotech IPO
  • Experience sharing on successful listing
  • Market potential in China and Hong Kong

*Awaiting final confirmation

MARKET PROFILES - CANCER AND IMMUNOTHERAPY

12:00 pm

  • Increasing prevalence of western cancers in Asia
  • Understanding the economics of treatment
  • Global shift in treatment paradigms
  • Need to address underserved Asian specific cancers
  • Need for Asia centric development

12:30 pm

  • Investment in clinical-stage biotechnology with T-Cell development focus
  • Latest technology in TCR-T cell therapy
  • Leading projects showcase and extending

1:00 pm

Networking Lunch

STRATEGIC OPPORTUNITY OPTIMISATION

2:00 pm

  • Build your case with unique and strong data support
  • Identify the best partner
  • Pursue the ideal deal structure- Legend-Janssen case study
  • Closing the deal with every available support

2:30 pm

  • Partnership opportunities
  • Next innovative drugs in China- Asia's largest new drug developer
  • Innovation and implementing landscapes

3:00 pm

  • Strategic research collaboration and license options
  • Better understanding and awareness about the benefits of AI-led technologies
  • Intelligent technologies showcase- AI, IoT, RPA, machine learning and data analysis

3:30 pm

Afternoon Break and Networking

BIOPHARMA DEVELOPMENT AND PRODUCTION 2018 CLOSING PLENARY SESSION

4:00 pm

  • Towards Industry 4.0 - where are we at now?
  • Reviewing latest disruptions in the biopharma industry
  • Corporate venture funds role in supporting Biotech commercialisation
  • Re-thinking manufacturing productivity and quality
  • Connecting human resources, data, machines and networks for better outcomes
  • Data management, product traceability and supply chain security
  • Managing costs on cold and non-cold chain logistics costs

5:00 pm

End of Conference Day 2

9:00 am

Investing in high potential pharma and biotech could be very profitable. Funds are needed from R&D stage to commercialisation. This full-day workshop will guide you through a step by step approach in capital raising, gaining the best exposure from your ROI and ultimately mange your risk.

Key Learning points included, but not limited to:

  • How to successfully raise finance for Biotech companies both matured and startups
  • Venture capital firms views on investing in biotech
  • Preparing for your strong pitch
  • Understanding regulatory framework
  • Key understanding on IRR

Co Located with BioPharma Development and Production Week, the Biotech Investment Summit 2018 will bring together top dealmakers from regional and international financial markets, and the biotech industry. Central to the conference objectives will be connecting investors with biotech, with extensive company showcases by CEO, CFO, CSO, emerging market opportunities and a specific focus on R&D investment in southeast Asia. In addition, practical tools for investment appraisal, capital raising models and deal structuring tactics will be discussed.

1:00 pm

End of workshop

연사

Ming-Qiang Zhang

Vice-President, Research & Development, Amgen, China

Dr. Carl Firth

Founder and Chief Executive Officer, Aslan Pharmaceuticals Pte Ltd, Singapore

Piers Ingram

Chief Executive Officer, Hummingbird Bioscience, Singapore

Jonathan Zhao

PhD, Co-founder and Chief Executive Officer, Hangzhou JUST Biotherapeutics, China

Ryan Viegas

Head of Logistics - APAC, Teva

Jinpian Diao-Piezunka

Head of Bioprocess Development, Sanofi, France

Dr Damian Tan

Managing Director, Vickers Venture Partners Singapore

Dr. Ming-Chu Hsu

Chairman and Chief Executive Officer, TaiGen Biotechnology, Taiwan

Jeffrey Lu

Co-Founder, Chief Executive Officer, Board Director, Engine Bioscience, Singapore

Emil Tsai

Chief Executive Officer, SyneuRx International (Taiwan) Corp

Wen Luo

CEO/CSO, Denovo Biopharma LLC, U.S.

Dr. Li Zhu

Chief Strategy Officer, GenScript and Legend Biotech, China

Dr. Poon Thong Yuen

Chief Strategy Officer, Histoindex, Singapore

Greg Collier

Managing Director & CEO, Invion Limited, Australia

Dr. Lim Xinhong

Venture Principal, Vickers Venture Partners Singapore

Eugene Hong

Senior Vice President, DBS Bank, Singapore

Marietta Wu

Managing Director, Quan Capital, China

Kenneth Noonan

Chief Executive Officer, Lightstone Singapore

Neo Kah Yean

Senior Vice President, Commercialisation for Biomedical Sciences ETPL A*STAR

Venkateswarlu Nelabhotla (N. Venkat)

CEO & Board Member, VYOME India

Vishal Doshi

Chief Executive Officer, AUM Biosciences, Singapore

Dr. Lietao LI

Chief Executive Officer, LION TCR, Singapore

Joseph Albert

Chief Technical Officer - Engineering and Projects, AJ Pharma Holding, Malaysia

Liang Tang

Vice President of Biologics Development and Manufacturing, WuXi Biologics, China

개최 기간 & 개최지

2018년 11월 1-2일

One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

파트너

Supporting Association

파트너

Supporting Association

The New Drug Founders Club was founded in March, 2015, to form a network for founders of companies focusing on innovative new drug R&D and of companies providing relevant services. The club is highly prestigious in that only founders of such companies and people well-recognized for having special and major contributions to new drug R&D in China (including China R&D heads of multinational companies, R&D heads of major domestic companies, partners of VC, and other nationally recognized leaders in new drug R&D) can be admitted to the club. This feature distinguish this club from any other professional organizations in China or the world. Currently there are about 235 members in the club, with several new applications reviewed for approval every month.

Media Partners

APBN serves as a knowledge exchange platform (print and online) to provide latest news and noteworthy information in biotechnology, healthcare, biomedical and pharmaceutical industry in Asia Pacific. Established in 1997, APBN is the first and only monthly magazine focused on biotechnology, healthcare, pharmaceutical and life science developments in China and other Asia Pacific countries. The main motivation of APBN is to bring biotechnology news in a comprehensive and concise manner to, but not limited to, clinicians, research scientists, students, and other industry professionals and experts.

Bentham Science Publishers is rendering a vital service in the quality publication that publishes over 100 peer-reviewed print and online scientific, technical and medical journals. These titles are indexed in recognized indexing agencies, such as Science Citation Index®, Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE etc. Some of the high impact titles which enjoy a wide reach and distribution are Current Gene Therapy (Impact Factor 4.906), Current Alzheimer Research (Impact Factor 3.796), Current Medicinal Chemistry (Impact Factor 3.715), and other popular titles.

Bentham has an extensive library of eBooks in the areas of science, technology, medicine, social sciences and humanities. Bentham eBooks publishes monographs, handbooks, conference proceedings, textbooks, review volumes, biographies and autobiographies.

Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.

Established since 1998, Bio-Equip is a leading website for lab equipments, reagents, consumables and bio services. Our users come from different fields like life science, medical research, pharmaceutical, biotechnology, modern agriculture, food safety and environment monitoring. Bio-Equip offer users a complete product directory which involves 158 product ranges among lab equipments, reagents, consumables, lab animals, bio services, cell lines, bio software and books.Serving users through two websites, www.bio-equip.com (Chinese) and www.bio-equip.cn (English), we own over 20,000 registered suppliers and more than 500,000 pieces of product and technical service information with details of product description, price, sample downloading, technical articles and videos.

BiotechEast provides information and services related to Taiwan's growing life science industries. Our services cover a wide scope, including marketing and business intelligence, investment sourcing, and partner identification and vetting. Founded in 2003, our mission is connecting Taiwan and overseas companies within this industry space, for the advancement of medical technology and the benefit of patients everywhere.

SOURCE newswire provides comprehensive coverage of breaking news for the life sciences industry in China. Daily updates allow timely tracking of key company developments, deal-making, and regulatory trends, with the primary focus on the pharmaceutical industry.

  • Daily News Briefs: receive 3-4 original articles each day
  • Email alerts on topics of interest by keyword.
  • Access a fully searchable archive of 20,940 original articles
  • Filter news by story type: company news; product/R&D trends; pricing and reimbursement decisions; and general policy developments
  • Ability to save and share favorite news items

 

KONGPOSH Publications is one of the leading Pharma publishers of India. Our publications are – The Pharma Review® is a bi-monthly article based journal. Covering news, views and articles on various fields of pharmacy including Clinical Trials, Biotechnology, Review/Research papers, Herbal Medicine and much more. Contributions received from Eminent pharma personalities from India as well as other countries which helps us to have a varied and rich content matter. Participation and distribution in over 20 Expos & Conferences worldwide each year. It is widely read by decision makers, middle management and the academia. The journal is Abstracted & Indexed in International Pharmaceutical Abstract & Chemical Abstract - USA, Index Copernicus - Poland & Ulrich’s Journal Database – USA for the quality of its content. Also available on our website and E-book format.

For regular complimentary link of the journal write to us on kongposhpub@gmail.com.

Lingmed Ltd was founded in 2013 in Hong Kong, currently we have offices in Shanghai and Beijing. Lingmed promotes three leading intelligence databases for healthcare professionals in China to make better decisions. Lingmed’s core products are healthcare intelligence databases; it covers global innovative assets & China market intelligence. Lingmed’s Products and Services have been recognized by Fortune 500 multinational pharma and device companies as well as Chinese local big pharmacos. In addition, we together with our partners in Europe provide partnering services to bridge European and Chinese pharmaceuticals with biotech companies, including valuation and market monitoring reports.

In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers. Pharmaceutical-Tech.com covers in-depth trends that shape industry dynamics and metamorphose global economics. With services like search engine optimization, global magazine, social media marketing, product video showcase, e-mail marketing, e-newsletter sponsorship, banner advertising, event marketing and micro-website within our platform, www.pharmaceutical-tech.com has created a recognition that spans over a global audience, thereby revolutionizing how businesses transact.

Pharma China (www.pharmachinaonline.com) is the most trusted English media and business intelligence service covering the Chinese pharmaceutical / biopharmaceutical industry and market.

Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China's burgeoning but increasingly complex healthcare marketplace, and is subscribed by most multinational pharmaceutical companies, leading CROs, investment banks and consulting firms active in China as well as relevant industry associations and government agencies.

  • Pharma China Journal Edition (monthly in PDF and Print)
  • Pharma China Web Edition (continuously-updated news, in-depth commentaries and online databases)
  • China Pharmaceutical Guide (the most comprehensive and authoritative reference for China's healthcare sector)

Pharma Focus Asia is a quarterly magazine from Ochre Media Pvt. Ltd. Pharma Focus Asia covers important issues and trends shaping the future of the Pharma industry across Asia and rest of the world. It is the leading Pharma title in print as well as digital versions serving the information needs of key executives from the world's leading pharmaceutical companies.

Informa's Pharma Intelligence is the trusted partner of the top 50 global pharmaceutical companies and the top 10 contract research organisations (CRO's) - providing timely intelligence and insight to help them make authoritative decisions.

From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management - we provide the global intelligence and insight to help advance our partners' initiatives in a fast changing market.

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.

Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.

PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

Technology Networks scientific communities offer today's scientists a single resource that contains unique, engaging, and entertaining content from their field of research.

World Pharma Today is a magazine and online avenue, a boulevard of the latest happenings in the pharmaceutical sector around the world. Our audience comprises of experts and prominent decision makers of the Pharma sector and we consider it as our duty to provide them with the current changes in the industry. We provide B2B media services boosting your online presence and increasing your visibility manifold.

메일링 서비스